Abstract
The effect of association of 1,3-bis-(2-chloroethyl)-l-nitrosourea (BCNU)- Rhein (RH) and BCNU-Lonidamine (LND) on the clonogenic activity of human glioma cells was evaluated. Both RH and LND modulate the lethal effect of BCNU regardless of the schedule of treatment. The analysis of the interactions, performed with the isbolar method according to Berembaum, demonstrates an additivity of the effects. The possible mechanisms as well as the implications for the design of brain tumor schedule treatment are discussed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anthraquinones / pharmacology*
-
Antineoplastic Agents / pharmacology*
-
Brain Neoplasms
-
Carmustine / pharmacology*
-
Cell Line
-
Cell Survival / drug effects*
-
Dose-Response Relationship, Drug
-
Drug Interactions
-
Glioblastoma
-
Humans
-
Indazoles / pharmacology*
-
Kinetics
-
NADH, NADPH Oxidoreductases / antagonists & inhibitors*
-
Tumor Stem Cell Assay
Substances
-
Anthraquinones
-
Antineoplastic Agents
-
Indazoles
-
NADH, NADPH Oxidoreductases
-
Carmustine
-
lonidamine
-
rhein